Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-01-10

Clinical Trial Update: The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial assessing the effects of lasmiditan on simulated driving performance in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lasmiditan (Lasmiditan)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Migraine | Phase 1 | Status: COMPLETED | Results posted: 2020-01-10